FDA Grants Accelerated Approval to ZENBEXUS Combination for Relapsed Multiple Myeloma | iPharmaCenter (ipharmacenter.com)
The US Food and Drug Administration has granted accelerated approval to ZENBEXUS, also known as iberdomide, in combination with daratumumab and hyaluronidase plus dexamethasone for adults with multipl...
#BREAKING - #FDA grants accelerated approval to #ZENBEXUS plus daratumumab and dexamethasone for relapsed or refractory #multiplemyeloma.
www.ipharmacenter.com/post/fda-gra...
#FDA #Myeloma $BMY